Literature DB >> 26153408

Necrotizing Scleritis, Conjunctivitis, and Other Pathologic Findings in the Left Eye and Brain of an Ebola Virus-Infected Rhesus Macaque (Macaca mulatta) With Apparent Recovery and a Delayed Time of Death.

Derron A Alves1, Anna N Honko2, Mark G Kortepeter3, Mei Sun4, Joshua C Johnson2, Luis A Lugo-Roman5, Lisa E Hensley2.   

Abstract

A 3.5-year-old adult female rhesus macaque (Macaca mulatta) manifested swelling of the left upper eyelid and conjunctiva and a decline in clinical condition 18 days following intramuscular challenge with Ebola virus (EBOV; Kikwit-1995), after apparent clinical recovery. Histologic lesions with strong EBOV antigen staining were noted in the left eye (scleritis, conjunctivitis, and peri-optic neuritis), brain (choriomeningoencephalitis), stomach, proximal duodenum, and pancreas. Spleen, liver, and adrenal glands, common targets for acute infection, appeared histologically normal with no evidence of EBOV immunoreactivity. These findings may provide important insight for understanding sequelae seen in West African survivors of Ebola virus disease. Published by Oxford University Press for the Infectious Diseases Society of America 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  Ebola virus; Ebola virus disease; brain; delayed death; eye; intramuscular; macaque; rhesus; sequelae

Mesh:

Year:  2015        PMID: 26153408      PMCID: PMC4707191          DOI: 10.1093/infdis/jiv357

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

1.  Real-time monitoring of cardiovascular function in rhesus macaques infected with Zaire ebolavirus.

Authors:  Mark G Kortepeter; James V Lawler; Anna Honko; Mike Bray; Joshua C Johnson; Bret K Purcell; Gene G Olinger; Robert Rivard; Matthew J Hepburn; Lisa E Hensley
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

2.  Pathologic findings associated with delayed death in nonhuman primates experimentally infected with Zaire Ebola virus.

Authors:  Thomas Larsen; Edward L Stevens; Kelly J Davis; Joan B Geisbert; Kathleen M Daddario-DiCaprio; Peter B Jahrling; Lisa E Hensley; Thomas W Geisbert
Journal:  J Infect Dis       Date:  2007-11-15       Impact factor: 5.226

Review 3.  Basic clinical and laboratory features of filoviral hemorrhagic fever.

Authors:  Mark G Kortepeter; Daniel G Bausch; Mike Bray
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

4.  Persistence of Ebola Virus in Ocular Fluid during Convalescence.

Authors:  Jay B Varkey; Jessica G Shantha; Ian Crozier; Colleen S Kraft; G Marshall Lyon; Aneesh K Mehta; Gokul Kumar; Justine R Smith; Markus H Kainulainen; Shannon Whitmer; Ute Ströher; Timothy M Uyeki; Bruce S Ribner; Steven Yeh
Journal:  N Engl J Med       Date:  2015-05-07       Impact factor: 91.245

5.  Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients.

Authors:  M A Bwaka; M J Bonnet; P Calain; R Colebunders; A De Roo; Y Guimard; K R Katwiki; K Kibadi; M A Kipasa; K J Kuvula; B B Mapanda; M Massamba; K D Mupapa; J J Muyembe-Tamfum; E Ndaberey; C J Peters; P E Rollin; E Van den Enden; E Van den Enden
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

6.  Late ophthalmologic manifestations in survivors of the 1995 Ebola virus epidemic in Kikwit, Democratic Republic of the Congo.

Authors:  K Kibadi; K Mupapa; K Kuvula; M Massamba; D Ndaberey; J J Muyembe-Tamfum; M A Bwaka; A De Roo; R Colebunders
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

7.  Isolated case of Ebola hemorrhagic fever with mucormycosis complications, Kinshasa, Democratic Republic of the Congo.

Authors:  Y Kalongi; K Mwanza; M Tshisuaka; N Lusiama; E Ntando; L Kanzake; W J Shieh; S R Zaki; E S Lloyd; T G Ksiazek; P E Rollin
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

8.  Outbreake of Marburg virus disease in Johannesburg.

Authors:  J S Gear; G A Cassel; A J Gear; B Trappler; L Clausen; A M Meyers; M C Kew; T H Bothwell; R Sher; G B Miller; J Schneider; H J Koornhof; E D Gomperts; M Isaäcson; J H Gear
Journal:  Br Med J       Date:  1975-11-29

9.  Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection.

Authors:  Thomas W Geisbert; Lisa E Hensley; Tom Larsen; Howard A Young; Douglas S Reed; Joan B Geisbert; Dana P Scott; Elliott Kagan; Peter B Jahrling; Kelly J Davis
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

10.  What we know about ocular manifestations of Ebola.

Authors:  Majid Moshirfar; Carlton R Fenzl; Zhan Li
Journal:  Clin Ophthalmol       Date:  2014-11-21
View more
  12 in total

1.  Identification and pathological characterization of persistent asymptomatic Ebola virus infection in rhesus monkeys.

Authors:  Xiankun Zeng; Candace D Blancett; Keith A Koistinen; Christopher W Schellhase; Jeremy J Bearss; Sheli R Radoshitzky; Shelley P Honnold; Taylor B Chance; Travis K Warren; Jeffrey W Froude; Kathleen A Cashman; John M Dye; Sina Bavari; Gustavo Palacios; Jens H Kuhn; Mei G Sun
Journal:  Nat Microbiol       Date:  2017-07-17       Impact factor: 17.745

Review 2.  Neurological Complications of Ebola Virus Infection.

Authors:  Bridgette Jeanne Billioux; Bryan Smith; Avindra Nath
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

3.  New Insights Into Marburg Virus Disease Pathogenesis in the Rhesus Macaque Model.

Authors:  Timothy K Cooper; Jennifer Sword; Joshua C Johnson; Amanda Bonilla; Randy Hart; David X Liu; John G Bernbaum; Kurt Cooper; Peter B Jahrling; Lisa E Hensley
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

4.  Peripheral Blood Biomarkers of Disease Outcome in a Monkey Model of Rift Valley Fever Encephalitis.

Authors:  Elizabeth R Wonderlich; Amy L Caroline; Cynthia M McMillen; Aaron W Walters; Douglas S Reed; Simon M Barratt-Boyes; Amy L Hartman
Journal:  J Virol       Date:  2018-01-17       Impact factor: 5.103

5.  Neurological Complications and Sequelae of Ebola Virus Disease.

Authors:  Bridgette Jeanne Billioux
Journal:  Curr Infect Dis Rep       Date:  2017-05       Impact factor: 3.663

6.  QTc interval prolongation during favipiravir therapy in an Ebolavirus-infected patient.

Authors:  Pierangelo Chinello; Nicola Petrosillo; Silvia Pittalis; Gianluigi Biava; Giuseppe Ippolito; Emanuele Nicastri
Journal:  PLoS Negl Trop Dis       Date:  2017-12-28

7.  Reflections on the Ebola Public Health Emergency of International Concern, Part 1: Post-Ebola Syndrome: The Silent Outbreak.

Authors:  Stanislaw P Stawicki; Richard P Sharpe; Sagar C Galwankar; Joan Sweeney; Noel Martins; Thomas J Papadimos; Donald Jeanmonod; Michael S Firstenberg; Lorenzo Paladino; Bhakti Hansoti; Manish Garg
Journal:  J Glob Infect Dis       Date:  2017 Apr-Jun

8.  Surviving Ebola: A historical cohort study of Ebola mortality and survival in Sierra Leone 2014-2015.

Authors:  Kevin Wing; Shefali Oza; Catherine Houlihan; Judith R Glynn; Sharon Irvine; Clare E Warrell; Andrew J H Simpson; Sabah Boufkhed; Alieu Sesay; Lahai Vandi; Sahr Charles Sebba; Pranav Shetty; Rachael Cummings; Francesco Checchi; Catherine R McGowan
Journal:  PLoS One       Date:  2018-12-27       Impact factor: 3.240

Review 9.  Pathogenesis of Uveitis in Ebola Virus Disease Survivors: Evolving Understanding from Outbreaks to Animal Models.

Authors:  Caleb Hartley; J Clay Bavinger; Sanjana Kuthyar; Jessica G Shantha; Steven Yeh
Journal:  Microorganisms       Date:  2020-04-20

10.  Case Series of Severe Neurologic Sequelae of Ebola Virus Disease during Epidemic, Sierra Leone.

Authors:  Patrick J Howlett; Anna R Walder; Durodami R Lisk; Felicity Fitzgerald; Stephen Sevalie; Marta Lado; Abdul N'jai; Colin S Brown; Foday Sahr; Foday Sesay; Jonathon M Read; Paul J Steptoe; Nicholas A V Beare; Reena Dwivedi; Marylou Solbrig; Gibrilla F Deen; Tom Solomon; Malcolm G Semple; Janet T Scott
Journal:  Emerg Infect Dis       Date:  2018-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.